InsiderFlow

ABCL

AbCellera Biologics Inc.$4.13-0.03 (-0.60%)
Prev Close$4.16·MCap$1.23B·P/E·Vol11.69M·Yield

Buys (12M)

1

$178.5K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$178.5K

Active Insiders

1

last 12 mo

Over the past 12 months, insider activity at AbCellera Biologics Inc. (ABCL) has been exclusively buying, with 1 insider purchase totaling $178.5K and 0 insider sales totaling $0.00. The most recent insider transaction was by Montalbano John S. (Director), who purchased $178.5K worth of shares on Nov 26, 2025. AbCellera Biologics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.23B.

ABCL Insider Trading Activity

DateInsiderTypeValue
Nov 26, 2025 Montalbano John S.Buy$178.5K
Mar 10, 2025 Montalbano John S.Buy$57.5K
Mar 6, 2025 Montalbano John S.Buy$140.6K
Nov 6, 2023 Montalbano John S.Buy$137.4K
Sep 22, 2023 Hayden Michael RBuy$98.2K
Sep 12, 2023 Lecault VeroniqueBuy$103.8K
Aug 8, 2023 Hayden Michael RBuy$177.0K
May 26, 2023 Booth AndrewBuy$99.3K
May 16, 2022 Lecault VeroniqueBuy$1.27M
May 12, 2022 Booth AndrewBuy$492.1K
Mar 4, 2022 Montalbano John S.Buy$85.4K
Mar 1, 2022 Montalbano John S.Buy$181.0K
Feb 28, 2022 Lecault VeroniqueBuy$2.00M
Dec 3, 2021 Lo AndrewBuy$1.22M
Nov 11, 2021 Booth AndrewBuy$993.1K
Aug 31, 2021 HAMER JOHNSell$5.08M
Aug 16, 2021 Montalbano John S.Buy$103.4K
Jun 22, 2021 Hayden Michael RSell$2.55M
Jun 9, 2021 Booth AndrewSell$30.60M
Jun 9, 2021 Hansen Carl L. G.Sell$144.77M2.0% OS
Jun 9, 2021 Lecault VeroniqueSell$25.50M

ABCL Insider Buying Activity

The following table shows recent insider purchases of AbCellera Biologics Inc. (ABCL) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Nov 26, 2025 Montalbano John S.Buy$178.5K
Mar 10, 2025 Montalbano John S.Buy$57.5K
Mar 6, 2025 Montalbano John S.Buy$140.6K
Nov 6, 2023 Montalbano John S.Buy$137.4K
Sep 22, 2023 Hayden Michael RBuy$98.2K
Sep 12, 2023 Lecault VeroniqueBuy$103.8K
Aug 8, 2023 Hayden Michael RBuy$177.0K
May 26, 2023 Booth AndrewBuy$99.3K
May 16, 2022 Lecault VeroniqueBuy$1.27M
May 12, 2022 Booth AndrewBuy$492.1K
Mar 4, 2022 Montalbano John S.Buy$85.4K
Mar 1, 2022 Montalbano John S.Buy$181.0K
Feb 28, 2022 Lecault VeroniqueBuy$2.00M
Dec 3, 2021 Lo AndrewBuy$1.22M
Nov 11, 2021 Booth AndrewBuy$993.1K
Aug 16, 2021 Montalbano John S.Buy$103.4K

ABCL Insider Selling Activity

The following table shows recent insider sales of AbCellera Biologics Inc. (ABCL) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Aug 31, 2021 HAMER JOHNSell$5.08M
Jun 22, 2021 Hayden Michael RSell$2.55M
Jun 9, 2021 Booth AndrewSell$30.60M
Jun 9, 2021 Hansen Carl L. G.Sell$144.77M2.0% OS
Jun 9, 2021 Lecault VeroniqueSell$25.50M

ABCL Insiders

Montalbano John S.

Director

Bought $883.7K
7 tradesLast: Nov 26, 2025
Hayden Michael R

Director

Bought $275.2KSold $2.55M
3 tradesLast: Sep 22, 2023
Lecault Veronique

Chief Operating Officer

Bought $3.37MSold $25.50M
4 tradesLast: Sep 12, 2023
Booth Andrew

Chief Financial Officer

Bought $1.58MSold $30.60M
4 tradesLast: May 26, 2023
Lo Andrew

Director

Bought $1.22M
1 tradesLast: Dec 3, 2021
HAMER JOHN

Director

Sold $5.08M
1 tradesLast: Aug 31, 2021
Hansen Carl L. G.

Chief Executive Officer

Sold $144.77M
1 tradesLast: Jun 9, 2021